Harbour BioMed Leverages PPD’s Biotech to Develop Innovative Therapeutics

September 3, 2019

Applied Clinical Trials

Harbour BioMed and Pharmaceutical Product Development, LLC have announced that HBM will use the services of PPD’s Biotech to develop innovative therapeutics in the areas of oncology and immunology.

To learn more, click here. 

Related Content: